Welt gets second digital therapeutic device approval in S. Korea
South Korea's Ministry of Food and Drug Safety announced on Wednesday that it has approved the cognitive therapy software "WELT-I" developed by We...
S.Korea's data market is estimated at $19 bn last year
The size of South Korea's data industry market is expected to exceed 25 trillion won ($18.96 billion) last year.According to the results of a surv...
Vaxcell-bio's NK cell therapy wins therapeutic approval for liver cancer
South Korean anti-cancer immunotherapy company Vaxcell-Bio Therapeutics announced on Friday that its natural killer (NK) cell therapy, Vax-NK/HCC, h...
Number of Netflix users in S. Korea drops 30% in a year
The number of Netflix users in South Korea has decreased by more than 30% in the past year since the recovery from COVID-19. According to Byun Jae-...
Verismo's CAR-T therapy designated fast-track status by FDA
Verismo Therapeutics, a US affiliate of South Korean pharmaceutical firm HLB Co., has received fast-track designation from the US Food and Drug Admi...
S.Korea seeks to restore volume of int'l flights to pre-COVID-19 levels
Resuming flights from Incheon International Airport to and from Prague, Czech Republic, and Zurich, Switzerland, to expand its air traffic, South Ko...
Top Korean food delivery app posts record profits
Woowa Brothers Corp., the operator of South Korea’s top food delivery app, posted a record profit in 2022, which also marked its first profit ...
S.Korea to cut COVID-19 quarantine from seven days to five in May
South Korea’s mandatory quarantine for confirmed COVID-19 patients from May will be cut from seven days to five, as the country is expected to...
S.Korea's E-Mart24 provides VAT refund service for foreign visitors
E-Mart24 Inc., the convenience store chain unit of Shinsegae Inc. Group, announced on Tuesday that it will resume the value-added tax (VAT) refund s...
US affiliate of Korea's cell therapy company NK Max eyes NYSE listing in 3Q
NKGen Biotech, the US affiliate of South Korea's natural killer (NK) cell therapy developer NK Max, on Friday said it signed a letter of intent (LOI) ...
Celltrion, Genuv sign agreement for antibody joint R&D
South Korean biopharmaceutical firm Celltrion Inc. announced on Tuesday a joint research and development agreement with Genuv, Inc., a domestic drug...
Korean convention sector enjoys increase in events post-pandemic
Coex Convention & Exhibition Center, the largest event complex in Seoul, was crowded on Friday for a smart factory and plant automation fair.&ld...
Phase 3 clinical plan for SK Bioscience's booster shot approved in Colombia
SK Bioscience Co., a leading South Korean vaccine and biotech company, announced on Monday that its phase 3 clinical trial plan for a heterogeneous ...
Korea's ST Pharm completes new R&D hub for gene therapy
ST Pharm Co., a South Korean drug raw material-producing subsidiary of Dong-A Socio Holdings, said on Friday that it has finished building an R&...
Samsung launches Galaxy S23 series in 55 markets worldwide
Samsung Electronics Co. announced on Friday the release of its latest flagship smartphone, the Galaxy S23 series, in 55 markets around the world, in...
S.Korea's Engel coefficient rises sharply amid COVID-19 pandemic
South Korea’s low-income households are feeling the pinch of rising food prices amid the COVID-19 pandemic, according to a report by a local t...
KAI expects 2023 sales to grow by a third, driven by fighter jets
Korea Aerospace Industries Ltd. (KAI), South Korea’s sole military aircraft manufacturer, said on Wednesday it aims to achieve 3.83 trillion w...
S.Korean shipbuilders rule world’s eco-friendly vessel market
South Korea’s shipbuilders have won more than half of the orders to build eco-friendly vessels so this year based on advanced technology to do...
Electric vehicles in S.Korea beat diesel cars in sales
Sales of electric vehicles (EVs) in South Korea last year including hybrids surpassed those of diesel cars for the first time due to the price of di...
HLB’s Rivoceranib, Hengrui's Camrelizumab approved as combination therapy in China
South Korea's HLB Co. announced on Thursday that the combination therapy of its drug candidate rivoceranib and Jiangsu Hengrui Pharmaceuticals Co., ...
China's alleged Korean trademark piracy surges during COVID-19
South Korean companies have witnessed a sharp increase in alleged trademark piracy in China over the past few years, as COVID-19 curbed their overse...
Galleria Dept. Store's sales from foreigners increase 500% for past 6 months
South Korea's department store group Galleria Department Store said on Tuesday that for the past six months (between August last year and January th...
Chong Kun Dang, Synaffix ink deal to introduce ADC technology
Chong Kun Dang Pharmaceutical Corp. said on Monday that it has signed a contract with Dutch biotechnology firm Synaffix B.V for the use of antibody-...
Jeju Air to resume flights on Incheon-Shizuoka route in March
Jeju Air Co., a South Korean budget airline, said on Thursday that it would resume its flights connecting Incheon with two small cities in Japan, Ma...
GC Cell's AB-101 NK therapy achieves FDA fast-track status
South Korea's bio firm GC Cell announced on Wednesday that its US affiliate Artiva Biotherapeutics has received fast-track designation from the US F...
Bridge Biotherapeutics, Pinotbio develop lung cancer treatment
South Korea's biotech companies Bridge Biotherapeutics Inc. and Pinotbio on Thursday said they will jointly develop new antibody-drug conjugates (AD...
Prestige Biopharma attains patent for solid cancer treatment antibody
Prestige Biopharma Korea said on Tuesday that it has obtained a domestic patent for the CTHRC1 neutralizing antibody of the drug candidate PBP1710. ...
Celltrion develops oral antibody drug with US bio company
South Korea's biopharmaceutical company Celltrion Inc. on Monday said it signed an R&D contract with US-based Rani Therapeutics on RT-111, an or...
Kolon signs MOU with Hanyang Univ. to develop gene therapy treatments
Kolon Industries Inc.'s Future Technology Institute said on Thursday that it had signed a memorandum of understanding with the Hanyang University In...
Hotels in top Seoul tourist area on sale due to rate hikes
South Korea's KB Asset Management Co. is set to sell two three-star hotel buildings in Myeong-dong, one of the most popular spots for foreign touris...
